Parabilis Medicines (PBLS)
Develops Helicon peptides for hard-to-reach intracellular protein targets.
$40.61
Pre-market+0.57 (+1.42%)
At close$40.04(+1.44%)
Something off on this page? Send us feedback.
EPSReportedEstimate
——————May '26Aug '26
Reported——————−$0.72−$2.32
Estimate———————−$0.17
Surprise———————−1,306.1%
RevenueReportedEstimate
——————May '26Aug '26
Reported———————$100.0K
Estimate———————$16.7M
Surprise———————−99.4%
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.17 | −$2.32 | −1,306.1% |
| May 2026 | — | −$0.72 | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | −$0.17 | −$2.32 | −1,306.1% | $16.7M | $100.0K | −99.4% | −4.7% |
| May 19, 2026 | — | −$0.72 | — | — | — | — | — |